Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis

Lai RuiMin; Wang MingFang; Zhu YueYong

doi:10.3969/j.issn.1001-5256.2016.09.021

Issue 9

Sep. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(9): 1739-1742

PDF( 1642 KB)

Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.09.021

Liver Research Center, The First Affiliated Hospital of Fujian Medical University

Published Date: 2016-09-20

Abstract

Abstract

Objective To evaluate liver reserve function in patients with hepatitis B cirrhosis using indocyanine green( ICG) clearance test,and to investigate the correlation of ICG clearance test with Child- Turcotte- Pugh( CTP) class and the Model for End- Stage Liver Disease( MELD) score in evaluating liver function. Methods A total of 127 patients with hepatitis B cirrhosis who were hospitalized in The First Affiliated Hospital of Fujian Medical University from January 2012 to January 2015 were enrolled. ICG clearance test was performed for all the patients,and the ICG plasma clearance( K value),effective liver blood flow( EHBF),and ICG retention at 15 minutes( ICG R15)were calculated. CTP class and MELD score were also determined. An analysis of variance was used for comparison between groups,the least significant difference t- test was used for comparison between any two groups,Spearman rank correlation was performed for correlation analysis,and the area under the receiver operating characteristic( ROC) curve was used to compare liver reserve function. Results Among all the patients with hepatitis B cirrhosis,63 had CTP class A,45 had CTP class B,and 19 had CTP class C hepatitis B cirrhosis. With the increasing CTP class,ICG R15 gradually increased,while EHBF and K value gradually decreased( F = 146. 96,91. 26 and 40. 94,P =0. 001,0. 003 and 0. 005). In the evaluation of liver function,ICG R15 was positively correlated with MELD score and CTP class( r = 0. 525 and 0. 838,both P < 0. 01) and was negatively correlated with EHBF and K value( r =- 0. 703 and- 0. 901,both P < 0. 01). The area under the ROC curve was 0. 85 for ICG R15 and 0. 65 for MELD score. Conclusion ICG test can accurately and dynamically reflect liver reserve function,and ICG R15 can evaluate liver reserve function better than CTP class and MELD score.
- hepatitis B,
- liver cirrhosis,
- indocyanine green

FullText(HTML)

References(15)

References

[1]NIE QH.Clinical practice of antiviral treatment for liver cirrhosis patients with chronic hepatitis B[J].Chin J Pract Intern Med,2014,34(6):568-571.(in Chinese)聂青和.核苷酸类似物药物治疗乙型肝炎肝硬化的临床实践[J].中国实用内科杂志,2014,34(6):568-571.

[2]FENG HL,LI Q,WANG L,et al.Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure[J].Hepatobiliary Pancreat Dis Int,2014,13(3):271-275.

[3]LIU YR,FANG ZP,YANG W,et al.Clinical evaluation of liver storage function by indocyanine green retention test[J].Chin J Hepatol,2010,18(6):476-477.(in Chinese)刘义荣,范作鹏,杨薇,等.吲哚菁绿滞留测试对肝储备功能的评价[J].中华肝脏病杂志,2010,18(6):476-477.

[4] Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Chin J Intern Med,2011,50(2):168-179.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].中华内科杂志,2011,50(2):168-179.

[5]FUNG J,POON RT,YU WC,et al.Use of liver stiffness measurement for liver resection surgery:correlation with indocyanine green clearance testing and post-operative outcome[J].PLoS One,2013,8(8):e72306.

[6]MULLIN EJ,METCALFE MS,MADDERN GJ.How much liver resection is too much?[J].Am J Surg,2005,190(1):87-97.

[7] DONG JH,ZHENG SS,CHEN XP,et al.Consensus on evaluation of hepatic functional reserve before hepatectomy(2011 version)[J].Chin J Dig Surg,2011,10(1):20-25.(in Chinese)董家鸿,郑树森,陈孝平,等.肝切除术前肝脏储备功能评估的专家共识(2011版)[J].中华消化外科杂志,2011,10(1):20-25.

[8]KAMEI H,FUJIMOTO Y,NAGAI S,et al.Impact of non-congestive graft size in living donor liver transplantation:new indicator for additional vein reconstruction in right liver graft[J].Liver Transpl,2007,13(9):1295-1301.

[9]PAN Z,WU XJ,LI JS,et al.Functional hepatic flow in patients with liver cirrhosis[J].World J Gastroenterol,2004,10(6):915-918.

[10]CHENG XP,ZHAO J,CHEN Y,et al.Comparison of the ability of the PDD-ICG clearance test,CTP,MELD,and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis[J].Eur J Gastroenterol Hepatol,2016,28(4):444-448.

[11]SHENG QS,LANG R,HE Q,et al.Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis[J].Hepatobiliary Pancreat Dis Int,2009,8(1):46-49.

[12]CRDENAS A,GINS P.Predicting mortality in cirrhosis--serum sodium helps[J].N Engl J Med,2008,359(10):1060-1062.

[13]ZIPPRICH A,KUSS O,ROGOWSKI S,et al.Incorporating indocyanin green clearance into the Model for End Stage Liver Disease(MELD-ICG)improves prognostic accuracy in intermediate to advanced cirrhosis[J].Gut,2010,59(7):963-968.

[14]NI LD,HU F,CHENG ML,et al.Prognostic value of MELD-1CG in HBV/HCV cirrhosis:a prospective study[J].Chin Hepatol,2013,18(7):439-443.(in Chinese)倪鎏达,胡峰,程明亮,等.MELD-ICG对HBV/HCV肝硬化预后的评估价值[J].肝脏,2013,18(7):439-443.

[15]GUPTA S,CHAWLA Y,KAUR J,et al.Indocyanine green clearance test(using spectrophotometry)and its correlation with model for end stage liver disease(MELD)score in Indian patients with cirrhosis of liver[J].Trop Gastroenterol,2012,33(2):129-134.

Relative Articles

[1]	Qian XUE, Chunling JIA, Jingtong WANG. Association between nonalcoholic fatty liver disease and osteoporosis in elderly patients[J]. Journal of Clinical Hepatology, 2024, 40(8): 1585-1590. doi: 10.12449/JCH240813
[2]	Shihua ZHANG, Chengzhi BAI, Chunyan LI, Limao XU, Huaqian XU, Shanhong TANG. Risk factors for the prognosis of elderly patients with hepatitis B virus-related acute-on-chronic liver failure and construction of a nomogram model for risk prediction[J]. Journal of Clinical Hepatology, 2024, 40(10): 1976-1984. doi: 10.12449/JCH241009
[3]	Jinhan ZHAO, Jing ZHANG, Yang ZHANG, Xiaoyi XU, Yusong GOU, Hangfei XU, Yan WAN, Jian WU. Association between the rs1800591 variation of the microsomal triglyceride transfer protein gene and the risk of nonalcoholic fatty liver disease in the elderly population[J]. Journal of Clinical Hepatology, 2023, 39(3): 552-561. doi: 10.3969/j.issn.1001-5256.2023.03.011
[4]	Guodong SHI, Zipeng LU, Kuirong JIANG. Diagnosis and treatment of dyspepsia associated with pancreatic tumors[J]. Journal of Clinical Hepatology, 2023, 39(12): 2770-2774. doi: 10.3969/j.issn.1001-5256.2023.12.004
[5]	Shengnan LYU, Xinyu PENG, Jian ZHANG, Huan LIU, Feng WEI. Establishment of a prognostic prediction model for pancreatic cancer based on endoplasmic reticulum stress-related genes[J]. Journal of Clinical Hepatology, 2023, 39(12): 2894-2900. doi: 10.3969/j.issn.1001-5256.2023.12.021
[6]	Jing WANG, Bin TAN, Zhijie ZHAO, Haochen ZHONG, Linlin QU. Genomic profile of pancreatic tumor in the coastal regions of Eastern China: A multicenter analysis of 40 cases[J]. Journal of Clinical Hepatology, 2022, 38(2): 409-414. doi: 10.3969/j.issn.1001-5256.2022.02.028
[7]	Tingting BI, Sihui HOU, Yan LIU. Expression of neural precursor cell expressed developmentally downregulated 4-1 in pancreatic cancer tissue and its clinical significance[J]. Journal of Clinical Hepatology, 2022, 38(3): 617-621. doi: 10.3969/j.issn.1001-5256.2022.03.024
[8]	Faquan ZHOU, Shi CHEN, Hongyu SUN, Lijun TANG. Correlation of systemic immune-inflammation index and pancreatic cancer prognosis, recent research progress[J]. Journal of Clinical Hepatology, 2022, 38(11): 2669-2672. doi: 10.3969/j.issn.1001-5256.2022.11.046
[9]	Jin XU, Xin JIANG, Yongfeng YAN, Rui ZHONG, Yan PENG, Xiaowei TANG, Chuankang TANG. Clinical features of elderly patients with acute pancreatitis aged ≥80 years[J]. Journal of Clinical Hepatology, 2021, 37(1): 142-146. doi: 10.3969/j.issn.1001-5256.2021.01.028
[10]	Wen QIN, Taiwen CHEN, Haiping ZHENG, Xianing HUANG, Xiaodong ZHU. Serum expression of angiopoietin-like protein 2 in pancreatic cancer patients with or without diabetes and its association with prognosis[J]. Journal of Clinical Hepatology, 2021, 37(6): 1398-1403. doi: 10.3969/j.issn.1001-5256.2021.06.034
[11]	Liu YueChen, Gu MengYu, Cheng Yu, Yang GuiYuan. An excerpt of radiation therapy for pancreatic cancer: Executive summary of an ASTRO clinical practice guideline (2019)[J]. Journal of Clinical Hepatology, 2020, 36(1): 50-52. doi: 10.3969/j.issn.1001-5256.2020.01.010
[12]	Jiang Hua, Wang YueHua, Liu JiaFeng, Liu DongBin, Zheng YaMin. Experience of individualized radiofrequency ablation in patients aged 65 years or older with liver tumors[J]. Journal of Clinical Hepatology, 2020, 36(2): 404-405. doi: 10.3969/j.issn.1001-5256.2020.02.035
[13]	CHEN Huan, LI Ting, WANG ZiJie, WANG ZhongQiong, LUO Gang, DENG MingMing. Influence of metabolic syndrome and its components on the prognosis of patients with pancreatic cancer[J]. Journal of Clinical Hepatology, 2020, 36(12): 2788-2794. doi: 10.3969/j.issn.1001-5256.2020.12.029
[14]	Chen FeiFan, Chen CongYing, Zhang YaJing, Zhang YiYi, Huang YinShi, Xu Min. Clinical features of patients with pancreatic neuroendocrine tumor and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2020, 36(2): 399-403. doi: 10.3969/j.issn.1001-5256.2020.02.034
[15]	Hou XiaoJia, Jin ZhenDong. Progress in additional new techniques of endoscopic ultrasound in treatment of pancreatic tumors[J]. Journal of Clinical Hepatology, 2015, 31(5): 671-673. doi: 10.3969/j.issn.1001-5256.2015.05.008
[16]	Zhang Yong, Chen YanShan. Application of fast track surgery in elderly patients during perioperative period of laparoscopic cholecystectomy[J]. Journal of Clinical Hepatology, 2014, 30(12): 1295-1298. doi: 10.3969/j.issn.1001-5256.2014.12.015
[17]	Pan Yan, Liu LuMing, Chen Zhen, Meng ZhiQiang, Lin JunHua, Chen Hao, Shen YeHua. Prognostic analysis of 190 elderly patients with pancreatic cancer treated by integrated traditional Chinese and Western medicine therapy[J]. Journal of Clinical Hepatology, 2014, 30(4): 330-334. doi: 10.3969/j.issn.1001-5256.2014.04.011
[18]	Chen Jie. Pathological and differential diagnoses of exocrine pancreatic tumors[J]. Journal of Clinical Hepatology, 2013, 29(1): 45-49.
[19]	Zhang WenYing, Jin ZhenDong. Endoscopic ultrasound -guided treatment for pancreatic tumor[J]. Journal of Clinical Hepatology, 2012, 28(8): 573-575+578.
[20]	Zhou XianShan, Hong HuiLan. Clinical analysis of elderly patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2008, 24(5): 364-366.

Supplements(0)

Cited By

Cited by
Periodical cited type(0)
Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2521) PDF downloads(458)

Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.09.021

Abstract

References

Relative Articles

Cited by

Periodical cited type(0)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.09.021

Abstract

References

Relative Articles

Cited by

Periodical cited type(0)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content